Statins and venous thrombosis: a story too good to be true?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.Journal of thrombosis and haemostasis : JTH · 2019
   Trial
2. Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study.Thrombosis journal · 2021
   Article
3. Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics.International journal of cardiology · 2017
   Article
4. The association of statin therapy with the risk of recurrent venous thrombosis.Journal of thrombosis and haemostasis : JTH · 2016 · on this map
   Observational

Corrections and comments

• Comment on
  Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.2012

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as